355 related articles for article (PubMed ID: 28604268)
1. Mucosal immunization with a flagellin-adjuvanted Hgp44 vaccine enhances protective immune responses in a murine Porphyromonas gingivalis infection model.
Puth S; Hong SH; Park MJ; Lee HH; Lee YS; Jeong K; Kang IC; Koh JT; Moon B; Park SC; Rhee JH; Lee SE
Hum Vaccin Immunother; 2017 Dec; 13(12):2794-2803. PubMed ID: 28604268
[TBL] [Abstract][Full Text] [Related]
2. A built-in adjuvant-engineered mucosal vaccine against dysbiotic periodontal diseases.
Puth S; Hong SH; Na HS; Lee HH; Lee YS; Kim SY; Tan W; Hwang HS; Sivasamy S; Jeong K; Kook JK; Ahn SJ; Kang IC; Ryu JH; Koh JT; Rhee JH; Lee SE
Mucosal Immunol; 2019 Mar; 12(2):565-579. PubMed ID: 30487648
[TBL] [Abstract][Full Text] [Related]
3. Vaccination with recombinant RgpA peptide protects against Porphyromonas gingivalis-induced bone loss.
Wilensky A; Potempa J; Houri-Haddad Y; Shapira L
J Periodontal Res; 2017 Apr; 52(2):285-291. PubMed ID: 27282938
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of the B subunit of cholera toxin in potentiating immune responses to the recombinant hemagglutinin/adhesin domain of the gingipain Kgp from Porphyromonas gingivalis.
Zhang P; Yang QB; Balkovetz DF; Lewis JP; Clements JD; Michalek SM; Katz J
Vaccine; 2005 Sep; 23(39):4734-44. PubMed ID: 15955601
[TBL] [Abstract][Full Text] [Related]
5. Induction of immune responses and prevention of alveolar bone loss by intranasal administration of mice with Porphyromonas gingivalis fimbriae and recombinant cholera toxin B subunit.
Takahashi Y; Kumada H; Hamada N; Haishima Y; Ozono S; Isaka M; Yasuda Y; Tochikubo K; Umemoto T
Oral Microbiol Immunol; 2007 Dec; 22(6):374-80. PubMed ID: 17949339
[TBL] [Abstract][Full Text] [Related]
6. Assessment of outer membrane vesicles of periodontopathic bacterium Porphyromonas gingivalis as possible mucosal immunogen.
Nakao R; Hasegawa H; Dongying B; Ohnishi M; Senpuku H
Vaccine; 2016 Aug; 34(38):4626-4634. PubMed ID: 27461458
[TBL] [Abstract][Full Text] [Related]
7. Arg-gingipain a DNA vaccine induces protective immunity against infection by Porphyromonas gingivalis in a murine model.
Yonezawa H; Ishihara K; Okuda K
Infect Immun; 2001 May; 69(5):2858-64. PubMed ID: 11292699
[TBL] [Abstract][Full Text] [Related]
8. Role of CD80 and CD86 in host immune responses to the recombinant hemagglutinin domain of Porphyromonas gingivalis gingipain and in the adjuvanticity of cholera toxin B and monophosphoryl lipid A.
Zhang P; Lewis JP; Michalek SM; Katz J
Vaccine; 2007 Aug; 25(33):6201-10. PubMed ID: 17629367
[TBL] [Abstract][Full Text] [Related]
9. Nasal vaccination with the 40-kilodalton outer membrane protein of Porphyromonas gingivalis and a nontoxic chimeric enterotoxin adjuvant induces long-term protective immunity with reduced levels of immunoglobulin E antibodies.
Momoi F; Hashizume T; Kurita-Ochiai T; Yuki Y; Kiyono H; Yamamoto M
Infect Immun; 2008 Jun; 76(6):2777-84. PubMed ID: 18411288
[TBL] [Abstract][Full Text] [Related]
10. Immunization by Arg-gingipain A DNA vaccine protects mice against an invasive Porphyromonas gingivalis infection through regulation of interferon-gamma production.
Yonezawa H; Kato T; Kuramitsu HK; Okuda K; Ishihara K
Oral Microbiol Immunol; 2005 Oct; 20(5):259-66. PubMed ID: 16101960
[TBL] [Abstract][Full Text] [Related]
11. Prevention of Porphyromonas gingivalis-induced oral bone loss following immunization with gingipain R1.
Gibson FC; Genco CA
Infect Immun; 2001 Dec; 69(12):7959-63. PubMed ID: 11705986
[TBL] [Abstract][Full Text] [Related]
12. Respiratory FimA-Specific Secretory IgA Antibodies Upregulated by DC-Targeting Nasal Double DNA Adjuvant Are Essential for Elimination of
Kataoka K; Kawabata S; Koyanagi K; Hashimoto Y; Miyake T; Fujihashi K
Front Immunol; 2021; 12():634923. PubMed ID: 33717178
[TBL] [Abstract][Full Text] [Related]
13. A peptide domain on gingipain R which confers immunity against Porphyromonas gingivalis infection in mice.
Genco CA; Odusanya BM; Potempa J; Mikolajczyk-Pawlinska J; Travis J
Infect Immun; 1998 Sep; 66(9):4108-14. PubMed ID: 9712755
[TBL] [Abstract][Full Text] [Related]
14. Transcutaneous immunization with a 40-kDa outer membrane protein of Porphyromonas gingivalis induces specific antibodies which inhibit coaggregation by P. gingivalis.
Maeba S; Otake S; Namikoshi J; Shibata Y; Hayakawa M; Abiko Y; Yamamoto M
Vaccine; 2005 Mar; 23(19):2513-21. PubMed ID: 15752838
[TBL] [Abstract][Full Text] [Related]
15. Sublingual vaccination with fusion protein consisting of the functional domain of hemagglutinin A of Porphyromonas gingivalis and Escherichia coli maltose-binding protein elicits protective immunity in the oral cavity.
Yuzawa S; Kurita-Ochiai T; Hashizume T; Kobayashi R; Abiko Y; Yamamoto M
FEMS Immunol Med Microbiol; 2012 Mar; 64(2):265-72. PubMed ID: 22066647
[TBL] [Abstract][Full Text] [Related]
16. Mucosal vaccination shapes the expression of salivary antibodies and establishment of CD8+ T-cells.
Polak D; Benzki-Namdar E; Houri-Haddad Y; Shapira L
J Periodontol; 2014 Jul; 85(7):991-7. PubMed ID: 24359165
[TBL] [Abstract][Full Text] [Related]
17. Intranasal administration of a flagellin-adjuvanted inactivated influenza vaccine enhances mucosal immune responses to protect mice against lethal infection.
Hong SH; Byun YH; Nguyen CT; Kim SY; Seong BL; Park S; Woo GJ; Yoon Y; Koh JT; Fujihashi K; Rhee JH; Lee SE
Vaccine; 2012 Jan; 30(2):466-74. PubMed ID: 22051136
[TBL] [Abstract][Full Text] [Related]
18. RgpA-Kgp peptide-based immunogens provide protection against Porphyromonas gingivalis challenge in a murine lesion model.
O'Brien-Simpson NM; Paolini RA; Reynolds EC
Infect Immun; 2000 Jul; 68(7):4055-63. PubMed ID: 10858222
[TBL] [Abstract][Full Text] [Related]
19. HGP44 induces protection against Porphyromonas gingivalis-Induced alveolar bone loss in mice.
Muramatsu K; Kokubu E; Shibahara T; Okuda K; Ishihara K
Clin Vaccine Immunol; 2011 May; 18(5):888-91. PubMed ID: 21430125
[TBL] [Abstract][Full Text] [Related]
20. Immunization with the RgpA-Kgp proteinase-adhesin complexes of Porphyromonas gingivalis protects against periodontal bone loss in the rat periodontitis model.
Rajapakse PS; O'Brien-Simpson NM; Slakeski N; Hoffmann B; Reynolds EC
Infect Immun; 2002 May; 70(5):2480-6. PubMed ID: 11953385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
